Firm Evaluation Johnson & Johnson Thesis

JNJ's flows over the past three years have been $16,055, $4,083 and $7,770 million respectively. Operating cash flows are higher still. JNJ has clearly demonstrated the ability to generate cash flow internally. In addition, JNJ has more debt than many of its peers. While JNJ is liquid, their liquidity ratios are inferior to the industry average. Their debt-to-equity ratio is higher than the average ratio of their peers as well. This indicates that for the industry, JNJ already holds a sufficiently high debt level. They could in theory handle more, but it would be unwise for them to issue more debt if they have other options. For JNJ, the use of cash flow from operations is a much better option. They have been able to generate cash flow consistently from operations, and in the past few years have used this to pay down some of their debt. The NASDAQ site puts analyst earnings calls at $4.53 for 2008 and $4.67 for 2009. At a 12% discount rate, the present value of these are $4.044 and $3.7208 respectively. To calculate using the residual income valuation approach we then add these to the book value of the equity today.

The book value per share is the book value of the equity divided by the number of shares outstanding. According to the 2007 annual report number of shares outstanding is 3120 million. There have been more shares issued, but the outstanding at the end of the 2007 fiscal year is clearly...

...

The book value of the equity is $43,319 million, including share value and retained earnings so the book value per share is $13.88. When added to the present value of the future earnings this gives us a value per share of JNJ of $21.64.
The 12% discount rate is entirely unreasonable for JNJ. The company has a beta of 0.49, so its risk is half of the market risk. An appropriate discount rate would be the cost of equity for JNJ, which if derived using CAPM would be approximately 4.47%. Therefore, 12% is far too high a discount rate for JNJ.

The fiscal year for JNJ ended December 30th, 2007. That was a Sunday. The close price on December 31st was $66.70. Therefore the market to book value was $66.70 / $13.88 = 4.805.

The number of years is will take for the economic value to reach the market value is as follows: $66.70 - $13.88 - $4.04 - $3.72 / $3.88 = 11.61 years. Therefore investors are assuming that the earnings for JNJ will grow faster than the earnings for the group as a whole. They are assuming that the present value of residual income will grow more quickly than the average, which will shorten the amount of time it takes for the economic value to equal the market value.

Work:

Inventory turn = sales / avg. inventory; $61,095 / 4999.5 = 12.22 times

Receivables turn = sales / avg. receivables: $61,095 / 9078…

Sources Used in Documents:

Forecast Inventory = forecast sales / inventory turn = 67493 / 12.22 = $5,523

Forecast Receivables = forecast sales / receivables turn = 67493 / 6.73 = $10,028

Link to JNJ 2007 Annual Report: http://files.shareholder.com/downloads/JNJ/463788344x0x171267/057640F8-B2C0-4B0F-9F54-7A24A553C3CE/2007AR.pdf


Cite this Document:

"Firm Evaluation Johnson & Johnson" (2008, November 12) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/firm-evaluation-johnson-amp-johnson-26829

"Firm Evaluation Johnson & Johnson" 12 November 2008. Web.19 April. 2024. <
https://www.paperdue.com/essay/firm-evaluation-johnson-amp-johnson-26829>

"Firm Evaluation Johnson & Johnson", 12 November 2008, Accessed.19 April. 2024,
https://www.paperdue.com/essay/firm-evaluation-johnson-amp-johnson-26829

Related Documents
Aloud or in Writing, Making
PAGES 55 WORDS 17261

Companies such as XYZ Widget Corporation are well situated to take advantage of burgeoning markets in developing nations, particularly in Asia and Africa. 2. XYZ can grow its business by expanding its operations to certain developing nations in ways that profit the company as well as the impoverished regions that are involved, particularly when marketing efforts are coordinated with nongovernmental organizations operating in the region. 3. Several constraints and challenges must

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit

Nursing 201 Nursing Process PaperClient ProfileThe patient is a white 80year old whose religion is unknown and was admitted on February 2, 2022, for a UTI infection. Care for the patient began on the day of admission. He is a father of three and a grandfather of five, living with his spouse. The social-economic status of the patient is low to middle class had a career as a factory worker.